title: The cerebellar channelopathy of multiple sclerosis.
authors.affiliation: From the Department of Neurology and Center for Neuroscience & Regeneration Research (S.G.W.), Yale University School of Medicine, New Haven, CT; Rehabilitation Research Center (S.G.W.), Veterans Administration Connecticut Healthcare System, West Haven; and Department of Neurology (O.K.), Mayo Clinic College of Medicine, Rochester, MN. stephen.waxman@yale.edu.
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Waxman
authors.affiliation: From the Department of Neurology and Center for Neuroscience & Regeneration Research (S.G.W.), Yale University School of Medicine, New Haven, CT; Rehabilitation Research Center (S.G.W.), Veterans Administration Connecticut Healthcare System, West Haven; and Department of Neurology (O.K.), Mayo Clinic College of Medicine, Rochester, MN.
authors.forename: Orhun
authors.initials: O
authors.lastname: Kantarci
mesh_terms: D000818:Animals; D002526:Cerebellar Diseases / Q000235:genetics*; D053447:Channelopathies / Q000235:genetics*; D005260:Female; D014644:Genetic Variation / Q000235:genetics*; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000235:genetics*; D062559:NAV1.8 Voltage-Gated Sodium Channel / Q000235:genetics* / Q000378:metabolism*; D026941:Sodium Channel Blockers / Q000008:administration & dosage* / Q000378:metabolism*
chemical_list: D062559:NAV1.8 Voltage-Gated Sodium Channel; D026941:Sodium Channel Blockers